175 related articles for article (PubMed ID: 1968266)
1. Gamma-type endorphins and brain dopaminergic systems.
van Ree JM; Elands J; Kiraly I; Wolterink G
Prog Clin Biol Res; 1990; 328():287-90. PubMed ID: 1968266
[No Abstract] [Full Text] [Related]
2. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
Van Ree JM; Elands J; Király I; Wolterink G
Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
[TBL] [Abstract][Full Text] [Related]
3. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
Arushanian EB
Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
[No Abstract] [Full Text] [Related]
4. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
van Ree JM; Igarashi J; Király I
NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic drugs and their action on different neuronal pathways.
Ungerstedt U; Herrera-Marschitz M; Forster C
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor mechanisms: behavioral and electrophysiological studies.
Ungerstedt U; Ljungberg T; Schultz W
Adv Biochem Psychopharmacol; 1978; 19():311-21. PubMed ID: 29451
[No Abstract] [Full Text] [Related]
7. Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
Király I; Van Ree JM
Neuropharmacology; 1984 May; 23(5):511-6. PubMed ID: 6204246
[TBL] [Abstract][Full Text] [Related]
8. Non-opiate beta-endorphin fragments and dopamine--III. gamma-Type endorphins and various neuroleptics counteract the hypoactivity elicited by injection of apomorphine into the nucleus accumbens.
Van Ree JM; Caffé AR; Wolterink G
Neuropharmacology; 1982 Nov; 21(11):1111-7. PubMed ID: 6184640
[TBL] [Abstract][Full Text] [Related]
9. [Alimentary conditioned reflex behavior in the rat following injection of 6-hydroxydopamine into the caudate nucleus and nucleus accumbens].
Zhukova EM; Spiridonov VK
Zh Vyssh Nerv Deiat Im I P Pavlova; 1986; 36(3):490-5. PubMed ID: 3092495
[TBL] [Abstract][Full Text] [Related]
10. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
Wolfarth S
Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
[No Abstract] [Full Text] [Related]
11. Subchronic treatment with the neuroleptic-like peptide desenkephalin-gamma-endorphin may decrease dopaminergic neurotransmission in the nucleus accumbens of rats.
Radhakishun FS; Westerink BH; Stoof JC; Wolterink G; van Ree JM
Eur Neuropsychopharmacol; 1994 Jun; 4(2):127-36. PubMed ID: 7919942
[TBL] [Abstract][Full Text] [Related]
12. Effects of risperidone on dopamine receptor subtypes in developing rat brain.
Moran-Gates T; Grady C; Shik Park Y; Baldessarini RJ; Tarazi FI
Eur Neuropsychopharmacol; 2007; 17(6-7):448-55. PubMed ID: 17175142
[TBL] [Abstract][Full Text] [Related]
13. Interactions of neurotensin with brain dopamine systems.
Nemeroff CB; Hernandez DE; Luttinger D; Kalivas PW; Prange AJ
Ann N Y Acad Sci; 1982; 400():330-44. PubMed ID: 6132577
[No Abstract] [Full Text] [Related]
14. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
[TBL] [Abstract][Full Text] [Related]
15. Non-opiate effects of neuropeptides derived from beta-endorphin.
De Wied D; Van Ree JM
Pol J Pharmacol Pharm; 1987; 39(5):623-32. PubMed ID: 2976164
[TBL] [Abstract][Full Text] [Related]
16. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
Radhakishun FS; Van Ree JM
Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
[TBL] [Abstract][Full Text] [Related]
17. Behavioral patterns related to dopamine neurotransmission: effect of acute and chronic antipsychotic drugs.
Ungerstedt U; Ljungberg T
Adv Biochem Psychopharmacol; 1977; 16():193-9. PubMed ID: 18882
[No Abstract] [Full Text] [Related]
18. Behavioral effects of non-opioid fragments of beta-endorphin.
van Ree JM; de Wied D
Prog Clin Biol Res; 1985; 192():277-84. PubMed ID: 2934744
[TBL] [Abstract][Full Text] [Related]
19. Behavioural data suggesting the plurality of central dopamine receptors.
Costentin J; Dubuc I; Protais P
Adv Biochem Psychopharmacol; 1983; 37():289-97. PubMed ID: 6138951
[No Abstract] [Full Text] [Related]
20. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
Crawley JH
Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
